We are live on ! Find out more
IBB icon

iShares Biotechnology ETF
IBB

863 hedge funds and large institutions have $7.66B invested in iShares Biotechnology ETF in 2021 Q2 according to their latest regulatory filings, with 97 funds opening new positions, 280 increasing their positions, 257 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more funds holding in top 10

Funds holding in top 10: 8 → 13 (+5)

39% more first-time investments, than exits

New positions opened: 97 | Existing positions closed: 70

2% more funds holding

Funds holding: 845 → 863 (+18)

9% more repeat investments, than reductions

Existing positions increased: 280 | Existing positions reduced: 257

0% less capital invested

Capital invested by funds: $7.67B → $7.66B (-$7.57M)

2% less call options, than puts

Call options by funds: $498M | Put options by funds: $510M

5.9% less ownership

Funds ownership: 76.67% → 70.77% (-5.9%)

Holders
863
Holders Change
+18
Holders Change %
+2.13%
% of All Funds
15.02%
Holding in Top 10
13
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+62.5%
% of All Funds
0.23%
New
97
Increased
280
Reduced
257
Closed
70
Calls
$498M
Puts
$510M
Net Calls
-$12.3M
Net Calls Change
+$483M

Top Buyers

1
E
Ergoteles
New York
+$77.5M
2
Bank of Nova Scotia
Bank of Nova Scotia
Ontario, Canada
+$77M
3
TIM
Total Investment Management
Arizona
+$50.9M
4
Twin Tree Management
Twin Tree Management
Texas
+$49.2M
5
Millennium Management
Millennium Management
New York
+$41.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$415M
2
Bank of America
Bank of America
North Carolina
-$200M
3
Goldman Sachs
Goldman Sachs
New York
-$197M
4
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$154M
5
JP Morgan Chase
JP Morgan Chase
New York
-$98M
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
851
Trust Company
Kansas
$4K – – –
MAM
852
Meeder Asset Management
Ohio
$4K +$2K +13 +108%
BL
853
Balentine LLC
Georgia
$3K -$6.16K -40 -70%
CI
854
CX Institutional
Indiana
$2K – – –
IF
855
Ironwood Financial
Arizona
$2K – – –
LWA
856
Lenox Wealth Advisors
New York
$2K – – –
RG
857
Retirement Group
California
$1K – – –
PI
858
PEAK6 Investments
Illinois
$1K +$770 +5 New
SIS
859
Sound Income Strategies
Florida
$1K +$924 +6 New
KJHP
860
K.J. Harrison & Partners
Ontario, Canada
$432 +$406K +2,635 New
BBHC
861
Brown Brothers Harriman & Co
New York
$59 – – –
Squarepoint
862
Squarepoint
New York
– -$21.2M -140,804 Closed
QIM
863
Quantitative Investment Management
Virginia
– -$10.8M -71,758 Closed
QAM
864
Q3 Asset Management
Michigan
– -$5.05M -33,485 Closed
BCI
865
Brinker Capital Investments
Pennsylvania
– -$4.99M -33,152 Closed
AIM
866
Aurora Investment Managers
Florida
– -$3.85M -25,568 Closed
FC
867
Ferris Capital
Massachusetts
– -$3.66M -24,314 Closed
TSS
868
Two Sigma Securities
New York
– -$3.47M -22,514 Closed
FIM
869
FWL Investment Management
Texas
– -$2.94M -19,534 Closed
HAS
870
HBW Advisory Services
California
– -$2.87M -19,078 Closed
FTUS
871
Flow Traders U.S.
New York
– -$2.44M -15,846 Closed
GP
872
Geneva Partners
Wisconsin
– -$2.25M -14,958 Closed
WAM
873
Wolverine Asset Management
Illinois
– -$2.11M -13,996 Closed
MIAN
874
Mariner Independent Advisor Network
Kansas
– -$1.82M -12,085 Closed
IAIM
875
International Assets Investment Management
Florida
– -$1.67M -11,039 Closed
33 34
35
36 37

IBB Hedge Fund Activity: Q2 2021 in Review

863 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in iShares Biotechnology ETF (IBB) for Q2 2021, worth a combined $7.66B — down 0.1% from $7.67B a quarter earlier.

Buyers outnumbered sellers: 97 funds opened new IBB positions and 70 closed out — a net gain of 27 holders — while 280 added to existing stakes and 257 trimmed.

The largest buyer was Ergoteles, adding an estimated $77.5M. The largest seller was Morgan Stanley, cutting an estimated $415M.

  • 863 institutional investors held iShares Biotechnology ETF (IBB) as of Q2 2021, up from 845 in Q1 2021.
  • Funds reported $7.66B of iShares Biotechnology ETF stock for Q2 2021, down 0.1% quarter-over-quarter.
  • 97 funds opened new iShares Biotechnology ETF positions in Q2 2021 and 70 closed out, a net change of +27 holders.
  • The largest iShares Biotechnology ETF buyer in Q2 2021 was Ergoteles, an estimated $77.5M added.
  • The largest iShares Biotechnology ETF seller in Q2 2021 was Morgan Stanley, an estimated $415M sold.

Based on aggregated 13F filings for Q2 2021.